Microneedle Drug Delivery Systems Market Size To Surpass USD 11.6 Billion By 2032 Fueled By Chronic Disease Burden And Demand For Patient-Friendly Solutions S&S Insider

(MENAFN- GlobeNewsWire - Nasdaq) North America leads the market, while Asia Pacific posts the fastest growth as governments invest in next-gen drug delivery infrastructure.

Austin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Microneedle Drug Delivery Systems Market Size & Growth Overview

According to S&S Insider, the global Microneedle Drug Delivery Systems Market was valued at USD 6.1 billion in 2023 and is projected to hit USD 11.6 billion by 2032, growing at a CAGR of 7.4% between 2024 and 2032. Growth is fueled by the rising prevalence of chronic conditions such as diabetes, cardiovascular disease, and cancer, coupled with patient demand for minimally invasive drug delivery methods. Government funding, technological breakthroughs in biodegradable and dissolvable microneedles, and rising adoption of self-administration therapies are accelerating market expansion.

Get free Sample Report of Microneedle Drug Delivery Systems Market:

Market Analysis

Chronic diseases account for 71% of all global deaths, according to the World Health Organization (WHO), making them one of the biggest drivers of healthcare demand. In the U.S., six in ten adults live with a chronic condition, with four in ten managing two or more. This has amplified the need for better drug delivery methods that minimize discomfort, improve adherence, and reduce hospital visits.

Microneedle drug delivery systems offer a pain-free, user-friendly alternative to conventional injections, making them especially popular among diabetic patients requiring regular insulin administration. The National Institutes of Health (NIH) has invested over USD 50 million into microneedle-related projects over the past five years, signaling strong institutional support. Increasing clinical trial activity across the U.S. and Europe, combined with rising healthcare expenditure in Asia Pacific, positions microneedle systems as a mainstream drug delivery solution in the coming decade.

Major Players Analysis Listed in the Microneedle Drug Delivery Systems Market Report are

• Kindeva Drug Delivery
• 3M
• Novartis International AG
• Becton Dickinson and Company
• AdminMed nanoBioSciences LLC
• B. Braun
• QuadMedicine
• Sorrento Therapeutics (Sofusa)
• Nanopass technologies limited
• Cardinal Health
• TheraJect Inc.

Microneedle Drug Delivery Systems Market Report Scope

Report Attributes	Details
Market Size in 2023	USD 6.1 Billion
Market Size by 2032	USD 11.6 Billion
CAGR	CAGR of 7.4% From 2024 to 2032
Base Year	2023
Forecast Period	2024-2032
Historical Data	2020-2022
Regional Analysis	North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)

Market Segmentation

By Type

The hollow microneedle segment dominated the market and accounted for the largest share of revenue, 26%. Hollow microneedles, however, are advantageous because they can provide liquid-based drugs, such as vaccines and biologics, directly to skin. They are minimally invasive and precise making them a good fit for diabetes management and vaccine delivery. The availability of recently developed better needles has allowed for the use of the device as point of care device, which suggests increased anonymised usage within clinical settings. This growth is additionally boosted by the rising demand in non-invasive drug delivery systems and the increasing prevalence of chronic illnesses that require frequent drug administration.

By Material

In 2023, the metal material segment dominated the market, capturing 29% of the revenue share. Materials such as stainless steel and titanium are used in general and its biocompatibility and structural permanence during breach into skin makes it a widely used material. Metal microneedles are commonly adopted for high-accuracy and stable drug delivery. Growth of interest in biodegradable polymers is expected to make it difficult for metal-based microneedles in the future. The segment is expected to be driven by the increasing need for safe and efficient drug delivery systems, especially in vaccine administration and chronic disease management.

By Application

The drug delivery segment dominated the market with the largest revenue share of 35% in 2023. Painless device includes microneedle-based systems for the delivery of vaccines, insulin, and other biologics. By avoiding the onset through the gastrointestinal tract, these systems ensure higher bioavailability and minimize side effects. Growth in this segment is driven by the increasing incidence of chronic diseases such as diabetes and cancer, which necessitate accurate and frequent drug delivery. In addition, the increasing emphasis on self-administration and better patient compliance are likely to propel the adoption of microneedle drug delivery systems in clinical and home-care settings.

Need Any Customization Research on Microneedle Drug Delivery Systems Market, Enquire Now:

Microneedle Drug Delivery Systems Market Key Segments

By Material

• Silicon
• Metal
• Polymer
• Others

By Type

• Solid
• Hollow
• Dissolving
• Coated
• Others

By Application

• Dermatology
• Drug Delivery
• Pain Management
• Cancer Therapy
• Vaccine Delivery
• Others

Regional Analysis

North America accounted for nearly 42% of the overall revenue share in 2023. The region is expected to dominate the market during the forecast period owing to the presence of developed healthcare infrastructure, high penetration of advanced drug delivery technologies, and increased research & development investments. The U.S. dominates the market with its increasing incidences of chronic diseases and rising demand for home-based self-administered drug delivery systems. Government initiatives, such as the National Institutes of Health (NIH) funding for microneedle research, are also supporting market growth.

The Asia-Pacific region is projected to show the highest growth during the forecast period due to rapid advancement in healthcare infrastructure, growing expenditure in healthcare, and increasing prevalence of chronic diseases. Microneedle technology is receiving massive investment from the likes of China, India, and Japan, all of which face an increasing burden from diabetes and infectious disease. Government programs like India s National Health Mission (NHM) are also facilitating the market growth, increasing access to advanced healthcare solutions.

Recent Developments

• 3M introduced its first hollow microneedle patch for painless vaccine delivery in 2023, responding to increased consumer demand for self-administration of vaccines.
• In January 2024, Micron Biomedical received FDA approval for its dissolvable microneedle patch for measles and rubella vaccination, marking a significant milestone in the field of microneedle-based vaccine delivery.

Buy the Microneedle Drug Delivery Systems Market Report Now:

About Us:

S&S Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: ...

MENAFN29092025004107003653ID1110125050